Galmed Announces ARRIVE Study Data

TEL AVIV, Israel, Feb. 14, 2018 -- (Healthcare Sales & Marketing Network) -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmedˮ or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver tar... Biopharmaceuticals Galmed Pharmaceuticals, Aramchol, nonalcoholic steatohepatitis, NASH
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news